[Clinical experiences with a methylhydrazine derivative (Natulan)].
作者信息
Hertz H, Hansen M M, Videbaek A A
出版信息
Ugeskr Laeger. 1966 Mar 17;128(11):316-24.
PMID:5331015
Abstract
摘要
相似文献
1
[Clinical experiences with a methylhydrazine derivative (Natulan)].[一种甲基肼衍生物（丙卡巴肼）的临床经验]
Ugeskr Laeger. 1966 Mar 17;128(11):316-24.
2
[A fundamentally new cytostatic: a methylhydrazine derivative (Natulan)].一种全新的细胞抑制剂：一种甲基肼衍生物（丙卡巴肼）
Ugeskr Laeger. 1966 Mar 17;128(11):313-6.
3
[First clinical experiences with methylhydrazine in treatment of malignant lymphogranuloma].[甲基肼治疗恶性淋巴肉芽肿的首次临床经验]
Minerva Med. 1965 Dec 12;56(99):4338-43.
4
[A new methylhydrazine derivative (Ro 4-6467 or Natulan) in the treatment of Hodgkin's disease. Study of 10 cases].
Rev Bras Med. 1966 Jul;23(7):483-9.
5
[Chemotherapy of malignant systemic diseases with a methylhydrazine derivative, Natulan].
Ugeskr Laeger. 1967 Nov 2;129(44):1472-6.
6
[Experiences with a new cytostatic of the methylhydrazine series (Natulan). With special reference to hematological side-effects].[甲基肼系列新型细胞抑制剂（丙卡巴肼）的使用经验。特别提及血液学副作用]
Schweiz Med Wochenschr. 1965 Sep 11;95(37):1233-40.
7
[Treatment of Hodgkin's disease with Natulan].
Minerva Med. 1965 Dec 15;56(100):4402-6.
8
[Treatment of some chronic hemoblastoses by a derivative of methylhydrazine (Natulan)].
Acta Genet Med Gemellol (Roma). 1968 Jan;17(1):178-9. doi: 10.1017/s1120962300026391.
9
Zotero 插件